Dishman Carbogen Amcis Reports Mixed Financial Results Amid Rising Interest Expenses in December 2024
Dishman Carbogen Amcis has announced its financial results for the quarter ending December 2024, showing significant year-on-year growth in both Profit Before Tax and Profit After Tax. However, the company faces challenges, including increased interest expenses and a declining Debtors Turnover Ratio, indicating mixed performance in the pharmaceuticals sector.
Dishman Carbogen Amcis has recently reported its financial results for the quarter ending December 2024, revealing a complex picture of performance within the pharmaceuticals and drugs industry. The company's score has undergone an adjustment in evaluation, reflecting a notable shift from the previous assessment.On the positive side, the Profit Before Tax (PBT) for the quarter stands at Rs 19.38 crore, showcasing a significant year-on-year growth of 126.79%. Similarly, the Profit After Tax (PAT) has reached Rs 4.28 crore, marking a robust year-on-year increase of 107.2%. These figures indicate a favorable near-term trend in profitability.
Conversely, the financial results also highlight challenges for Dishman Carbogen. The interest expense has risen to Rs 48.78 crore, representing a quarter-on-quarter growth of 33.17%. This increase suggests a reliance on borrowing, as evidenced by the debt-equity ratio, which has reached its highest level at 0.44 times over the past five half-year periods. Additionally, the Debtors Turnover Ratio has declined to 3.71 times, indicating a slower pace in settling receivables.
Overall, Dishman Carbogen's recent financial results present a mixed landscape of growth and challenges.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
